EGRX
Eagle Pharmaceuticals, Inc.
EGRX
EGRX
Delisted
EGRX was delisted on the 2nd of October, 2024.
189 hedge funds and large institutions have $1.07B invested in Eagle Pharmaceuticals, Inc. in 2018 Q3 according to their latest regulatory filings, with 29 funds opening new positions, 80 increasing their positions, 42 reducing their positions, and 21 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
189
Holders Change
+6
Holders Change %
+3.28%
% of All Funds
4.33%
Holding in Top 10
3
Holding in Top 10 Change
-2
Holding in Top 10 Change %
-40%
% of All Funds
0.07%
New
29
Increased
80
Reduced
42
Closed
21
Calls
$18.7M
Puts
$16.3M
Net Calls
+$2.42M
Net Calls Change
+$2.07M
Top Buyers
| 1 |
BlackRock
New York
|
+$21.5M |
| 2 |
State Street
Boston,
Massachusetts
|
+$19.7M |
| 3 |
Invesco
Atlanta,
Georgia
|
+$8.75M |
| 4 |
MCM
Matarin Capital Management
New York
|
+$6.74M |
| 5 |
IAM
Iridian Asset Management
Westport,
Connecticut
|
+$5.16M |
Top Sellers
| 1 |
LSV Asset Management
Chicago,
Illinois
|
-$34.9M |
| 2 |
PWAM
Park West Asset Management
San Francisco,
California
|
-$25.1M |
| 3 |
Lazard Asset Management
New York
|
-$24.4M |
| 4 |
Victory Capital Management
San Antonio,
Texas
|
-$10.8M |
| 5 |
MWNA
Marshall Wace North America
New York
|
-$6.79M |
